Cardio-COVID Study

I'm Interested!

Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes” (Cardio-COVID)

Sex at Birth: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: Yes
Type: Others
Trial Phase: NA
Conditions Being Studied: COVID-19

Study Purpose

The objective of this study is to understand the immunologic foundations of heart disease which can occur as a result of COVID19.

Who Can Participate

Age: 18 and older

Principal Investigator
David Zidar MD PhD

Department/Division
Heart and Vascular (Translational Sciences)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: STUDY20201563
StudyID: 2021-0590
ClinicalTrials.gov: N/A

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422